TY - JOUR
T1 - Joint analysis of psychiatric disorders increases accuracy of risk prediction for schizophrenia, bipolar disorder, and major depressive disorder
AU - Maier, Robert
AU - Moser, Gerhard
AU - Chen, Guo-Bo
AU - Ripke, Stephan
AU - Coryell, William
AU - Potash, James B
AU - Scheftner, William A
AU - Shi, Jianxin
AU - Weissman, Myrna M
AU - Hultman, Christina M
AU - Landén, Mikael
AU - Levinson, Douglas F
AU - Kendler, Kenneth S
AU - Smoller, Jordan W
AU - Wray, Naomi R
AU - Lee, S Hong
AU - Cross-Disorder Working Group of the Psychiatric Genomics Consortium
AU - Kuntsi, Jonna
AU - McGuffin, Peter
AU - Lewis, Cathryn
AU - Farmer, Anne
AU - Craig, Ian
AU - Breen, Gerome
AU - Asherson, Philip
AU - Young, Allan
AU - Sonuga-Barke, Edmund
PY - 2015/2/5
Y1 - 2015/2/5
N2 - Genetic risk prediction has several potential applications in medical research and clinical practice and could be used, for example, to stratify a heterogeneous population of patients by their predicted genetic risk. However, for polygenic traits, such as psychiatric disorders, the accuracy of risk prediction is low. Here we use a multivariate linear mixed model and apply multi-trait genomic best linear unbiased prediction for genetic risk prediction. This method exploits correlations between disorders and simultaneously evaluates individual risk for each disorder. We show that the multivariate approach significantly increases the prediction accuracy for schizophrenia, bipolar disorder, and major depressive disorder in the discovery as well as in independent validation datasets. By grouping SNPs based on genome annotation and fitting multiple random effects, we show that the prediction accuracy could be further improved. The gain in prediction accuracy of the multivariate approach is equivalent to an increase in sample size of 34% for schizophrenia, 68% for bipolar disorder, and 76% for major depressive disorders using single trait models. Because our approach can be readily applied to any number of GWAS datasets of correlated traits, it is a flexible and powerful tool to maximize prediction accuracy. With current sample size, risk predictors are not useful in a clinical setting but already are a valuable research tool, for example in experimental designs comparing cases with high and low polygenic risk.
AB - Genetic risk prediction has several potential applications in medical research and clinical practice and could be used, for example, to stratify a heterogeneous population of patients by their predicted genetic risk. However, for polygenic traits, such as psychiatric disorders, the accuracy of risk prediction is low. Here we use a multivariate linear mixed model and apply multi-trait genomic best linear unbiased prediction for genetic risk prediction. This method exploits correlations between disorders and simultaneously evaluates individual risk for each disorder. We show that the multivariate approach significantly increases the prediction accuracy for schizophrenia, bipolar disorder, and major depressive disorder in the discovery as well as in independent validation datasets. By grouping SNPs based on genome annotation and fitting multiple random effects, we show that the prediction accuracy could be further improved. The gain in prediction accuracy of the multivariate approach is equivalent to an increase in sample size of 34% for schizophrenia, 68% for bipolar disorder, and 76% for major depressive disorders using single trait models. Because our approach can be readily applied to any number of GWAS datasets of correlated traits, it is a flexible and powerful tool to maximize prediction accuracy. With current sample size, risk predictors are not useful in a clinical setting but already are a valuable research tool, for example in experimental designs comparing cases with high and low polygenic risk.
KW - Bipolar Disorder
KW - Depressive Disorder, Major
KW - Genetic Testing
KW - Genetics, Medical
KW - Humans
KW - Linear Models
KW - Mental Disorders
KW - Multifactorial Inheritance
KW - Multivariate Analysis
KW - Polymorphism, Single Nucleotide
KW - Risk Assessment
KW - Schizophrenia
U2 - 10.1016/j.ajhg.2014.12.006
DO - 10.1016/j.ajhg.2014.12.006
M3 - Article
C2 - 25640677
SN - 0002-9297
VL - 96
SP - 283
EP - 294
JO - American Journal of Human Genetics
JF - American Journal of Human Genetics
IS - 2
ER -